http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2006143770-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate | 2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2006143770-A |
| titleOfInvention | APPLICATION OF COMPOUNDS OF OPIOID RECEPTOR ANTAGONISTS FOR THE PREVENTION AND / OR TREATMENT OF DISEASES RELATED TO TARGET WITH CALCIUM-NEURINE |
| abstract | 1. The use of the compounds of formula (I) where R is C-Calkenyl; C 1-6 cycloalkylalkyl, wherein cycloalkyl is C 1-6 cycloalkyl and alkyl is C 1-6 alkyl; C 1-6 cycloalkenylalkyl, wherein cycloalkenyl is C 1-6 cycloalkenyl and alkyl is C 1-6 alkyl; C-Carylalkyl, wherein aryl is C-Caryl and alkyl is C-Calkyl; C-Carylalkenyl, wherein aryl is C-Caryl and alkenyl is C-Calkenyl; R is hydrogen, hydroxy, C-Calkoxy; C-alkenyloxy; C-Carylalkyloxy, wherein aryl is C-Caryl and alkyloxy is C-Calkyloxy; C-Carylalkenyloxy, wherein aryl is C-Caryl and alkenyloxy is C-Calkenyloxy; C-alkanoyloxy; C-Carylalkanoyloxy where aryl is C-Caryl and alkanoyloxy is C-Calkanoyloxy; R is hydrogen, C-Calkyl; C-alkenyl; C-Carylalkyl, wherein aryl is C-Caryl and alkyl is C-Calkyl; C-Carylalkenyl, wherein aryl is C-Caryl and alkenyl is C-Calkenyl; hydroxy (C-C) alkyl; alkoxyalkyl wherein alkoxy is C 1 -C 4 alkoxy and alkyl is C 1-6 alkyl; COH; CO (C 1-6 alkyl); R 1 is hydrogen, hydroxy; C-alkoxy; C-Carylalkyloxy, wherein aryl is C-Caryl and alkyloxy is C-Calkyloxy; C-alkenyloxy; C-alkanoyloxy; C-Carylalkanoyloxy where aryl is C-Caryl and alkanoyloxy is C-Calkanyloxy; C-Cialkyloxyalkoxy, wherein alkyloxy is Ci-Cialkyloxy and alkoxy is Ci-Cialkoxy; R and R are each independently hydrogen; OH; C-alkoxy; C-Sal |
| priorityDate | 2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.